OACC Oaktree Acquisition Corp. III Life Sciences
Blank Checks · Nasdaq · SEC CIK 2029769 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2025Q1*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | — | — | — | — | — | — | — | — |
| Operating income | -$2.38M | -$261,958 | -$456,538 | -$255,496 | -$225,579 | -$269,810 | -$444,802 | -$303,711 |
| Net income | -$452,553 | $1.60M | $1.39M | $1.79M | $1.97M | $1.87M | $1.66M | $1.38M |
| EPS (diluted) | — | — | — | — | — | — | — | — |
| Balance sheet | ||||||||
| Cash & equivalents | $1.23M | $1.18M | $1.28M | $1.43M | $1.33M | $1.39M | $1.28M | $1.36M |
| Current assets | $1.25M | $1.26M | $1.42M | $1.55M | $1.48M | $1.56M | $1.48M | $1.56M |
| Total assets | $208.21M | $206.54M | $204.83M | $203.11M | $201.25M | $199.18M | $197.24M | $195.25M |
| Current liabilities | $3.85M | $1.73M | $1.62M | $1.30M | $1.23M | $1.12M | $1.06M | $727,323 |
| Total liabilities | $10.87M | $8.75M | $8.64M | $8.32M | $8.25M | $8.14M | $8.08M | $7.75M |
| Shareholders' equity | -$9.62M | -$7.49M | -$7.23M | -$6.77M | -$6.76M | -$6.54M | -$6.52M | -$6.07M |
| Cash flow statement | ||||||||
| Operating cash flow | -$204,067 | -$97,260 | -$158,035 | -$143,876 | -$56,518 | -$146,124 | -$75,561 | -$89,687 |
| Investing cash flow | $250,000 | — | — | $250,000 | $0 | — | — | -$191.99M |
Free plan shows the latest 8 periods; Pro shows all 9 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.